Is Zero A Must?: The Impact Of Residual Symptoms In Major Depressive Disorder
Archived Webinar | August 24, 2016
Not a member? Sign up for free!
Join us as we continue our efforts towards improving the future of mental health care through information, discussion, and collaboration. Sign up today for instant access to all PsychU offerings. Membership is free!
While remission is the goal in treatment of patients with major depressive disorder (MDD), persistent symptoms are common, even among remitters, and can negatively affect patient functioning and outcomes. In this webinar, Allen Doederlein, Robert Nelson, MD, and Madhukar Trivedi, MD, review the prevalence and burden of MDD, discuss the burden of inadequate treatment of…
PsychU offers private, personalized educational programs, both online and in-person, on a range of topics, including: schizophrenia, major depressive disorder, bipolar disorder, care coordination, quality standards, and health care policy.
Any PsychU member can request a presentation for their region or organization for free.
This link will take you outside of the PsychU community website.
By selecting continue, you will be leaving PsychU. The destination site to which you will be redirected is not controlled or endorsed by Otsuka Pharmaceutical Development & Commercialization, Inc. (OPDC), Otsuka America Pharmaceutical, Inc. (OAPI), and / or Lundbeck, LLC.